Keefer J F, Mong S
Department of Immunology, SmithKline Beecham Pharmaceuticals, King of Prussia, Pennsylvania.
J Pharmacol Exp Ther. 1990 Oct;255(1):120-7.
Substance P (SP) is one of the endogenous tachykinin peptides implicated in neurogenic inflammation and may be critically involved in diseases as diverse as asthma, arthritis and inflammatory bowel disease. The current study was initiated to identify a rich source of SP receptor that would be amenable for studying the regulatory mechanism of the receptor. By using a radioligand receptor binding technique, sheep ileal smooth muscle membranes showed a much higher density of [3H]SP specific binding than other non-neural rat or sheep tissues and organs surveyed. Of the protease inhibitors tested, only phosphoramidon, a specific and potent enkephalinase inhibitor, prevented the degradation of [3H]SP and enhanced [3H]SP binding to the membrane. [3H]SP binding to the specific binding sites in the membranes was time-dependent and reached a steady state after 60 min at 22 degrees C in 25 mM Tris.NH3 (pH 7.4). Calcium and magnesium ions enhanced [3H]SP specific binding. Saturation binding studies showed that the dissociation constant (KD) and the density of maximum binding sites for [3H]SP specific binding were 0.54 nM and 83 fmol/mg of protein, respectively. The specificity of the [3H]SP labeled sites was SP greater than (4-11) SP greater than eledoisin greater than spantide greater than neurokinin-A greater than D-Pro2D-Phe7D-Trp9-SP. Neurokinin-B and senktide showed no inhibition of [3H]SP binding.(ABSTRACT TRUNCATED AT 250 WORDS)
P物质(SP)是一种内源性速激肽肽,与神经源性炎症有关,可能在哮喘、关节炎和炎症性肠病等多种疾病中起关键作用。本研究旨在确定一个富含SP受体的来源,以便研究该受体的调节机制。通过使用放射性配体受体结合技术,绵羊回肠平滑肌膜显示出比所检测的其他非神经大鼠或绵羊组织和器官更高密度的[3H]SP特异性结合。在所测试的蛋白酶抑制剂中,只有磷酰胺,一种特异性且有效的脑啡肽酶抑制剂,能阻止[3H]SP的降解并增强[3H]SP与膜的结合。[3H]SP与膜中特异性结合位点的结合具有时间依赖性,在22℃下于25 mM Tris·NH3(pH 7.4)中60分钟后达到稳态。钙和镁离子增强[3H]SP特异性结合。饱和结合研究表明,[3H]SP特异性结合的解离常数(KD)和最大结合位点密度分别为0.54 nM和83 fmol/mg蛋白质。[3H]SP标记位点的特异性为SP大于(4 - 11)SP大于eledoisin大于spantide大于神经激肽 - A大于D - Pro2D - Phe7D - Trp9 - SP。神经激肽 - B和senktide对[3H]SP结合无抑制作用。(摘要截短于250字)